EndoPure Life Sciences, Lda.

Portuguese biotech company founded in 2017 in Porto, specialized in research, development, manufacturing and distribution of natural cannabinoid APIs and derived products under strict cGMP pharmaceutical quality standards. Distributes to 30 countries and is a leader in the South American market, especially Brazil. Produces broad-spectrum CBD, full-spectrum, isolated cannabinoids and water-soluble formulations.